Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug 6:14:231.
doi: 10.3389/fncel.2020.00231. eCollection 2020.

Insight Into the Role of Ferroptosis in Non-neoplastic Neurological Diseases

Jianwei Lei  1 , Zhihua Chen  1 , Shuxin Song  1 , Chunpeng Sheng  1 , Sihui Song  1 , Jianming Zhu  1
Affiliations
Review

Insight Into the Role of Ferroptosis in Non-neoplastic Neurological Diseases

Jianwei Lei et al. Front Cell Neurosci. .

Abstract

Ferroptosis is an iron-dependent form of cell death characterized by the accumulation of intracellular lipid reactive oxygen species (ROS). Ferroptosis is significantly different from other types of cell death including apoptosis, autophagy, and necrosis, both in morphology and biochemical characteristics. The mechanisms that are associated with ferroptosis include iron metabolism, lipid oxidation, and other pathophysiological changes. Ferroptosis inducers or inhibitors can influence its occurrence through different pathways. Ferroptosis was initially discovered in tumors, though recent studies have confirmed that it is also closely related to a variety of neurological diseases including neurodegenerative disease [Alzheimer's disease (AD), Parkinson's disease (PD), etc.] and stroke. This article reviews the definition and characteristics of ferroptosis, the potential mechanisms associated with its development, inducers/inhibitors, and its role in non-neoplastic neurological diseases. We hope to provide a theoretical basis and novel treatment strategies for the treatment of central nervous system diseases by targeting ferroptosis.

Keywords: Alzheimer’s disease; Parkinson’s disease; ferroptosis; iron; neurodegenerative disease; stroke.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mechanisms of ferroptosis and non-neoplastic neurological diseases.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Agrawal S., Fox J., Thyagarajan B., Fox J. H. (2018). Brain mitochondrial iron accumulates in Huntington’s disease, mediates mitochondrial dysfunction, and can be removed pharmacologically. Free Radic. Biol. Med. 120, 317–329. 10.1016/j.freeradbiomed.2018.04.002 - DOI - PMC - PubMed
    1. Ahmad S., Elsherbiny N. M., Haque R., Khan M. B., Ishrat T., Shah Z. A., et al. . (2014). Sesamin attenuates neurotoxicity in mouse model of ischemic brain stroke. Neurotoxicology 45, 100–110. 10.1016/j.neuro.2014.10.002 - DOI - PubMed
    1. Alim I., Caulfield J. T., Chen Y., Swarup V., Geschwind D. H., Ivanova E., et al. . (2019). Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke. Cell 177, 1262.e25–1279.e25. 10.1016/j.cell.2019.03.032 - DOI - PubMed
    1. Andrabi S. S., Parvez S., Tabassum H. (2020). Ischemic stroke and mitochondria: mechanisms and targets. Protoplasma 257, 335–343. 10.1007/s00709-019-01439-2 - DOI - PubMed
    1. Ayton S., Faux N. G., Bush A. I., Alzheimer’s Disease Neuroimaging Initiative . (2015). Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE. Nat. Commun. 6:6760. 10.1038/ncomms7760 - DOI - PMC - PubMed

LinkOut - more resources